# The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure

> **NCT02527109** · PHASE2,PHASE3 · COMPLETED · sponsor: **RDD Pharma Ltd** · enrollment: 339 (actual)

## Conditions studied

- Chronic Anal Fissure

## Interventions

- **DRUG:** Nifedipine

## Key facts

- **NCT ID:** NCT02527109
- **Lead sponsor:** RDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-06-15
- **Final completion:** 2018-08-22
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02527109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02527109, "The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02527109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*